Company Profile
What Does This Company Do?
Elder Pharmaceuticals Ltd is engaged in manufacturing and marketing of prescription pharmaceutical brands, surgical and medical devices. It focuses on vagisil range of feminine personal hygiene products. Sector
Healthcare Industry
Drug Manufacturers - Major Stock Type
— Employees
3,609 Fiscal Year Ends
March
Key Stats
| | Stock | Ind Avg | | | Relative to Industry |
|---|
| | | | Price/Earnings TTM | 9.7 | --- | | | | | Price/Book | 1.1 | --- | | | | | Price/Sales TTM | 0.7 | --- | | | | | Rev Growth (3 Yr Avg) | 20.3 | --- | | | | | EPS Growth (3 Yr Avg) | -3.9 | --- | | | | | Operating Margin % TTM | 15.7 | --- | | | | | Net Margin % TTM | 6.7 | --- | | | | | ROE TTM | 11.6 | --- | | | | | Debt/Equity | 0.0 | --- | | | | | |
Financials
Financials 532322
| |
Annual |
|
Quarterly |
|
|
|
|
| |
2011-03 |
2010-03 |
2009-03 |
|
2011-03 |
2007-03 |
| Income Statement |
| Revenue |
9,595 |
7,216 |
6,203 |
|
— |
— |
| Operating Income |
1,504 |
1,138 |
962 |
|
— |
— |
| Net Income |
627 |
472 |
608 |
|
— |
— |
| Earnings Per Share |
32.55 |
26.25 |
33.05 |
|
— |
— |
| Shares Outstanding |
20 |
19 |
19 |
|
— |
— |
| Balance Sheet |
| Current Assets |
9,878 |
5,702 |
5,393 |
|
— |
— |
| Non Current Assets |
7,527 |
6,221 |
4,611 |
|
— |
— |
| Total Assets |
17,406 |
11,923 |
10,004 |
|
— |
— |
| Current Liabilities |
2,238 |
1,238 |
1,163 |
|
— |
— |
| Total Liabilities |
11,283 |
7,014 |
6,207 |
|
— |
— |
| Stockholders' Equity |
6,123 |
4,909 |
3,796 |
|
—
|
—
|
| Cash Flow |
| Cash From Operations |
431 |
-910 |
1,361 |
|
431 |
709 |
| Capital Expenditures |
-2,152 |
-1,503 |
-1,039 |
|
-2,152 |
-1,015 |
| Free Cash Flow |
-1,721 |
-2,413 |
322 |
|
-1,721 |
-306 |
| In millions except "EPS". Currency in INR. |
Dividends
| Declared Date | 08/17/11 | | Ex-Dividend Date | 09/15/11 | | Latest Indicated Dividend Amount | 3.0000 | | Projected Yield | 1.0% |
Recent Dividends | Date | Type | Amount |
|---|
| 09/15/11 | Cash Dividend | 3.0000 | | 09/16/10 | Cash Dividend | 3.0000 | | 09/17/09 | Cash Dividend | 2.5000 |
Purchase Options | Direct Investment | No | | Dividend Reinvestment Plan | No |
|